Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study of Ixabepilone Administered as a 24-Hour Infusion in Patients With Advanced Solid Malignancies

NCT00162136 is registered in ClinicalTrials.gov with R-Pharm as lead sponsor.

NCT NCT00162136
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00162136 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study of Ixabepilone Administered as a 24-Hour Infusion in Patients With Advanced Solid Malignancies
Lead sponsor
R-Pharm
Phase
Phase 1
Overall status
Completed
Start date
September 30, 2005
Completion date
July 31, 2008
Enrollment
35 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

solid malignancies